FB-1001

N/A

Report date: 2023/03/21 10:38:11

Base Information

Drug NameFB-1001
Drug Alias NameFB_-1001FB-1001FB1001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 stimulants
TargetsNeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsGlaucoma, Angle-ClosureGlaucomaOptic Neuropathy, Ischemic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator Companies4b Technologies (Suzhou) Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active Companies4b Technologies (Suzhou) Ltd4B Technologies Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma, Angle-ClosureGlaucomaOptic Neuropathy, Ischemic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A